Segment Information (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2017 USD ($) segment	Jun. 30, 2016 USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment			2
Segment Reporting Information [Line Items]
Total revenue	$ 335,523	$ 112,685	$ 578,070	$ 112,685
Interest income, net	72,342	107,818	150,196	211,151
Loss from operations	8,876,965	11,470,951	17,223,214	21,166,745
Operating Segments | Consumer Operations
Segment Reporting Information [Line Items]
Total revenue	335,523	112,685	578,070	112,685
Interest income, net	0	0	0	0
Loss from operations	2,760,496	2,841,848	4,748,306	5,771,202
Operating Segments | Drug Development
Segment Reporting Information [Line Items]
Total revenue	0	0	0	0
Interest income, net	0	0	0	0
Loss from operations	3,960,335	5,907,774	7,788,616	9,966,817
Corporate
Segment Reporting Information [Line Items]
Total revenue	0	0	0	0
Interest income, net	72,342	107,818	150,196	211,151
Loss from operations	$ 2,156,134	$ 2,721,329	$ 4,686,292	$ 5,428,726